| 注册
首页|期刊导航|北京大学学报(医学版)|2022-2024年青岛市10~59岁女性自身免疫性甲状腺病的患病率特征

2022-2024年青岛市10~59岁女性自身免疫性甲状腺病的患病率特征

陈欣 杨君婷 郭金鑫 李淑雅 刘志科 朱颖靓 李奉娟 詹思延 郭娟娟

北京大学学报(医学版)2025,Vol.57Issue(3):507-513,7.
北京大学学报(医学版)2025,Vol.57Issue(3):507-513,7.DOI:10.19723/j.issn.1671-167X.2025.03.014

2022-2024年青岛市10~59岁女性自身免疫性甲状腺病的患病率特征

Prevalence characteristics of autoimmune thyroid disease in women aged 10-59 years in Qingdao City from 2022 to 2024

陈欣 1杨君婷 1郭金鑫 1李淑雅 1刘志科 1朱颖靓 2李奉娟 2詹思延 3郭娟娟4

作者信息

  • 1. 北京大学公共卫生学院流行病与卫生统计学系,北京 100191||重大疾病流行病学教育部重点实验室(北京大学),北京 100191
  • 2. 青岛市疾病预防控制中心,山东青岛 266033
  • 3. 北京大学公共卫生学院流行病与卫生统计学系,北京 100191||重大疾病流行病学教育部重点实验室(北京大学),北京 100191||北京大学第三医院临床流行病学研究中心,北京 100191||北京大学人工智能研究院智慧公众健康研究中心,北京 100871
  • 4. 青岛市第三人民医院,山东青岛 266041
  • 折叠

摘要

Abstract

Objective:To analyze the characteristics of Hashimoto thyroiditis(HT)and Graves disease(GD),two autoimmune thyroid diseases aged 10-59 in Qingdao City from 2022 to 2024,and to provide scientific basis for making targeted prevention and treatment measures.Methods:A cross-sectional study design was adopted,based on the data of the Regional Health Information Platform in Qingdao,the con-firmed cases of HT and GD from 2022 to 2024 were included,and combined with the data of the seventh population census,the three-year and annual prevalence rates of HT and GD were calculated,and the time trend of annual prevalence was analyzed by Cochran-Armitage trend test.The distribution characte-ristics of HT and GD prevalence in different age groups and regions were analyzed,and Chi-square test was used to compare the differences between the groups.Results:The total number of HT patients among women aged 10-59 in Qingdao City from 2022 to 2024 was 40 362.The proportion of HT patients in 30-34 years old was the highest(19.83%).The proportion of HT patients in Huangdao District was the highest(17.72%).The three-year prevalence of HT was 1 206.53/100 000.In 2022-2024,the annual prevalence of HT increased significantly(P<0.001),from 385.32/100 000 in 2022 to 1 206.32/100 000 in 2024.The three-year prevalence of HT was significantly different in age distribution(P<0.001).The three-year prevalence of HT in 25-29 years(2 354.44/100 000)and 35-39 years(2 022.20/100 000)was higher than that in other age groups,showing a bimodal distribution.There were significant differences in the three-year prevalence of HT in different regions(P<0.001),among which the three-year prevalence of HT in Shinan District was the highest(2 392.90/100 000),followed by Licang Dis-trict(1 492.41/100 000),and Laixi City was the lowest(659.940/100 000).The total number of GD patients was 2 095,among which the proportion of GD patients in the 35-39 age group was the highest(15.42%),and the proportion of GD patients from Jimo District was the highest(12.27%).From 2022 to 2024,the three-year prevalence rate of GD was 62.63/100 000,and the annual prevalence rate of GD showed an increasing trend(P<0.001),from 20.33/100 000 in 2022 to 62.63/100 000 in 2024.There were significant differences in the prevalence of GD by age(P<0.001).The three-year prevalence of GD reached the highest value in the 25-29 age group(98.90/100 000),followed by the 35-39 age group(85.21/100 000),and the lowest in the 10-14 age group(14.43/100 000).In the regional distribution,there were significant differences in the 3-year prevalence of GD(P<0.001).Laoshan District had the highest three-year prevalence of GD(107.58/100 000),followed by Shinan District(97.83/100 000)and Huangdao District(28.92/100 000).Conclusion:The three-year pre-valence of HT and GD in females aged 10-59 years in Qingdao City from 2022 to 2024 is low,but the annual prevalence is on the rise,and the three-year prevalence of HT and GD in females aged 25-39 years is higher than that in other age groups,so it is necessary to strengthen the screening and monitoring of this population.

关键词

桥本甲状腺炎/格雷夫斯病/患病率/女性/流行病学

Key words

Hashimoto thyroiditis/Graves disease/Prevalence/Female/Epidemiology

分类

预防医学

引用本文复制引用

陈欣,杨君婷,郭金鑫,李淑雅,刘志科,朱颖靓,李奉娟,詹思延,郭娟娟..2022-2024年青岛市10~59岁女性自身免疫性甲状腺病的患病率特征[J].北京大学学报(医学版),2025,57(3):507-513,7.

基金项目

国家自然科学基金(82330107、72361127500)Supported by the National Natural Science Foundation of China(82330107,72361127500) (82330107、72361127500)

北京大学学报(医学版)

OA北大核心

1671-167X

访问量0
|
下载量0
段落导航相关论文